AJCN 19th International Congress of Nutrition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, R. J
Right arrow Articles by Sánchez-Lozada, L. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, R. J
Right arrow Articles by Sánchez-Lozada, L. G
Agricola
Right arrow Articles by Johnson, R. J
Right arrow Articles by Sánchez-Lozada, L. G
American Journal of Clinical Nutrition, Vol. 86, No. 4, 899-906, October 2007
© 2007 American Society for Nutrition


REVIEW ARTICLE

Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease1,2,3

Richard J Johnson, Mark S Segal, Yuri Sautin, Takahiko Nakagawa, Daniel I Feig, Duk-Hee Kang, Michael S Gersch, Steven Benner and Laura G Sánchez-Lozada

1 From the Division of Nephrology and Department of Medicine, University of Florida, Gainesville, FL (RJJ, MSS, YS, TN, and MSG); the Division of Pediatric Nephrology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX (DIF); the Division of Nephrology, Ewha Woman's University College of Medicine, Seoul, Korea (D-HK); the Foundation for Applied Molecular Evolution, Gainesville, FL (SB); and the Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico (LGS-L)

Currently, we are experiencing an epidemic of cardiorenal disease characterized by increasing rates of obesity, hypertension, the metabolic syndrome, type 2 diabetes, and kidney disease. Whereas excessive caloric intake and physical inactivity are likely important factors driving the obesity epidemic, it is important to consider additional mechanisms. We revisit an old hypothesis that sugar, particularly excessive fructose intake, has a critical role in the epidemic of cardiorenal disease. We also present evidence that the unique ability of fructose to induce an increase in uric acid may be a major mechanism by which fructose can cause cardiorenal disease. Finally, we suggest that high intakes of fructose in African Americans may explain their greater predisposition to develop cardiorenal disease, and we provide a list of testable predictions to evaluate this hypothesis.

Key Words: Fructose • uric acid • sugar • arteriosclerosis • endothelial dysfunction • hypertension • obesity • chronic kidney disease • metabolic syndrome




This article has been cited by other articles:


Home page
Fam PractHome page
C. H Halsted
Perspectives on obesity and sweeteners, folic acid fortification and vitamin D requirements
Fam. Pract., December 1, 2008; 25(suppl_1): i44 - i49.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. G. Sanchez-Lozada, M. Le, M. Segal, and R. J Johnson
How safe is fructose for persons with or without diabetes?
Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1189 - 1190.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. Livesey and R. Taylor
Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies
Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1419 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Shapiro, W. Mu, C. Roncal, K.-Y. Cheng, R. J. Johnson, and P. J. Scarpace
Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1370 - R1375.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. R. Vasselli
Fructose-induced leptin resistance: discovery of an unsuspected form of the phenomenon and its significance. Focus on "Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding," by Shapiro et al.
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1365 - R1369.
[Full Text] [PDF]


Home page
NEJMHome page
D. I. Feig, D.-H. Kang, and R. J. Johnson
Uric Acid and Cardiovascular Risk
N. Engl. J. Med., October 23, 2008; 359(17): 1811 - 1821.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
O. Glushakova, T. Kosugi, C. Roncal, W. Mu, M. Heinig, P. Cirillo, L. G. Sanchez-Lozada, R. J. Johnson, and T. Nakagawa
Fructose Induces the Inflammatory Molecule ICAM-1 in Endothelial Cells
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1712 - 1720.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Brandstatter, S. Kiechl, B. Kollerits, S. C. Hunt, I. M. Heid, S. Coassin, J. Willeit, T. D. Adams, T. Illig, P. N. Hopkins, et al.
Sex-Specific Association of the Putative Fructose Transporter SLC2A9 Variants With Uric Acid Levels Is Modified by BMI
Diabetes Care, August 1, 2008; 31(8): 1662 - 1667.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. N. Feinglos and S. E. Totten
Are You What You Eat, or How Much You Eat?: The Case of Type 2 Diabetes Mellitus
Arch Intern Med, July 28, 2008; 168(14): 1485 - 1486.
[Full Text] [PDF]


Home page
GutHome page
G. Marchesini, V. Ridolfi, and V. Nepoti
Hepatotoxicity of fast food?
Gut, May 1, 2008; 57(5): 568 - 570.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R J. Hine
Time to get specific about dietary carbohydrates, affected populations, and diseases
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1062 - 1062.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. A Bray
Reply to RJ Hine and JS White
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1064 - 1065.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. S White
No unique role for fructose sweeteners in obesity or cardiorenal disease
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1062 - 1063.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. G. Sanchez-Lozada, E. Tapia, P. Bautista-Garcia, V. Soto, C. Avila-Casado, I. P. Vega-Campos, T. Nakagawa, L. Zhao, M. Franco, and R. J. Johnson
Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F710 - F718.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
E. Ritz
Cardiovascular Literature--Beyond Nephrology
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 317 - 323.
[Full Text] [PDF]


Home page
J. Nutr.Home page
R. Villegas, X. O. Shu, Y.-T. Gao, G. Yang, T. Elasy, H. Li, and W. Zheng
Vegetable but Not Fruit Consumption Reduces the Risk of Type 2 Diabetes in Chinese Women
J. Nutr., March 1, 2008; 138(3): 574 - 580.
[Abstract] [Full Text] [PDF]


Home page
JWatch PediatricsHome page
Is High-Fructose Corn Syrup the New Trans Fat?
Journal Watch Pediatrics and Adolescent Medicine, December 12, 2007; 2007(1212): 5 - 5.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition